Omalizumab in chronic inducible urticaria: A retrospective, real-life study
- 8 July 2021
- journal article
- letter
- Published by Elsevier BV in Annales de Dermatologie et de Vénéréologie
- Vol. 148 (4), 262-265
- https://doi.org/10.1016/j.annder.2021.04.010
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Treatments of cold urticaria: A systematic reviewJournal of Allergy and Clinical Immunology, 2019
- Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidenceJournal of Allergy and Clinical Immunology, 2018
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticariaAllergy, 2018
- Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trialJournal of Allergy and Clinical Immunology, 2017
- Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background TherapyThe Journal of Allergy and Clinical Immunology: In Practice, 2015
- Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible UrticariaJAMA Dermatology, 2014
- Effective treatment of idiopathic chronic cold urticaria with omalizumab: Report of 3 casesJournal of the American Academy of Dermatology, 2013
- Treatment of Severe Cold Contact Urticaria with Omalizumab: Case ReportsCase Reports in Dermatology, 2012
- Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical UrticariaInternational Archives of Allergy and Immunology, 2010
- Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgEJournal of Allergy and Clinical Immunology, 2006